CeriBell, Inc.(CBLL)
$23.95—
CeriBell, Inc.(CBLL)
NASDAQ
$23.95—
Q4 2026 EPS Estimate
$-0.50
Nov 3, 2026 · Reports after close
Revenue Estimate
$29M
Analyst Sentiment
Wall St. Consensus
Buy4 analysts·Low coverage
75
Score
4 Buy (100%)0 Hold (0%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
4100%
Hold
00%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$26.00
+8.6%
Consensus
$26.00
+8.6%
Bull
$26.00
+8.6%
12-Month Target Range4 analysts
$26.00$26.00$26.00
Current $23.95Consensus
Current Price
$23.95
Upside to Consensus
$2.05
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+27.31%
EPS—
FY2028
Rev+27.65%
EPS—
FY2029
Rev+22.33%
EPS—
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $116M | $147M | $188M | $230M | $281M |
| Low | $115M | $146M | $182M | $227M | $277M |
| High | $116M | $148M | $195M | $233M | $285M |
| EBITDA Avg | $-79M | $-100M | $-128M | $-156M | $-191M |
| Low | $-79M | $-101M | $-132M | $-159M | $-194M |
| High | $-78M | $-99M | $-124M | $-154M | $-189M |
| EBIT Avg | $-80M | $-102M | $-130M | $-159M | $-194M |
| Low | $-80M | $-102M | $-135M | $-162M | $-197M |
| High | $-80M | $-101M | $-126M | $-157M | $-192M |
| Net Income Avg | $-75M | $-59M | $-54M | $-42M | $-41M |
| Low | $-76M | $-66M | $-63M | $-43M | $-41M |
| High | $-69M | $-48M | $-28M | $-41M | $-40M |
| EPS Avg | $-1.97 | $-1.56 | $-1.28 | $-1.15 | $-1.11 |
| Low | $-2.07 | $-1.80 | $-1.74 | $-1.18 | $-1.13 |
| High | $-1.88 | $-1.30 | $-0.78 | $-1.14 | $-1.09 |
| Analysts (Rev / EPS) | 6 / 6 | 6 / 6 | 4 / 4 | 2 / 1 | 2 / 1 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $29M | $32M | $34M | $36M | $37M | $41M | $44M | $46M |
| Low | $29M | $32M | $34M | $35M | $37M | $40M | $44M | $45M |
| High | $30M | $32M | $34M | $36M | $38M | $41M | $45M | $46M |
| EBITDA Avg | $-20M | $-22M | $-23M | $-24M | $-25M | $-28M | $-30M | $-31M |
| Low | $-20M | $-22M | $-23M | $-25M | $-26M | $-28M | $-30M | $-32M |
| High | $-20M | $-22M | $-23M | $-24M | $-25M | $-27M | $-30M | $-31M |
| EBIT Avg | $-20M | $-22M | $-24M | $-25M | $-26M | $-28M | $-31M | $-32M |
| Low | $-20M | $-22M | $-24M | $-25M | $-26M | $-28M | $-31M | $-32M |
| High | $-20M | $-22M | $-23M | $-25M | $-25M | $-28M | $-30M | $-32M |
| Net Income Avg | $-19M | $-17M | $-16M | $-15M | $-14M | $-13M | $-10M | $-10M |
| Low | $-21M | $-18M | $-16M | $-15M | $-15M | $-13M | $-10M | $-10M |
| High | $-17M | $-16M | $-15M | $-15M | $-14M | $-13M | $-10M | $-10M |
| EPS Avg | $-0.51 | $-0.44 | $-0.41 | $-0.40 | $-0.38 | $-0.35 | $-0.26 | $-0.26 |
| Low | $-0.56 | $-0.46 | $-0.42 | $-0.41 | $-0.38 | $-0.35 | $-0.26 | $-0.26 |
| High | $-0.46 | $-0.42 | $-0.41 | $-0.40 | $-0.37 | $-0.34 | $-0.25 | $-0.26 |
| Analysts (Rev / EPS) | 5 / 4 | 5 / 4 | 4 / 1 | 4 / 1 | 4 / 1 | 4 / 1 | 3 / 2 | 3 / 2 |